Trial Site Detail
Drug: |
Bezuclastinib |
|||
|---|---|---|---|---|
Trial: |
Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Recruiting |
|||
Cleveland Clinic Taussig Cancer Center9500 Euclid Ave |
Principal Investigator: |
|
|---|---|
Contact: |
Cancer Answer Line 216-444-7923 (866) 223-810 |
Activation Status of this Site: |
Available |
Notes about this Site: |
|
Cleveland Clinic Taussig Cancer Center Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.